.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Mallinckrodt
Cerilliant
Citi
Argus Health
UBS
Farmers Insurance
Johnson and Johnson
Novartis
Julphar

Generated: July 26, 2017

DrugPatentWatch Database Preview

Entacapone - Generic Drug Details

« Back to Dashboard

What are the generic sources for entacapone and what is the scope of entacapone patent protection?

Entacapone
is the generic ingredient in two branded drugs marketed by Macleods Pharms Ltd, Aurobindo Pharma Ltd, Wockhardt Ltd, Sun Pharma Global, Mylan Pharms Inc, and Orion Pharma, and is included in six NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Entacapone has forty-five patent family members in thirty-seven countries.

There are nineteen drug master file entries for entacapone. Sixteen suppliers are listed for this compound.

Summary for Generic Name: entacapone

Tradenames:2
Patents:1
Applicants:6
NDAs:6
Drug Master File Entries: see list19
Suppliers / Packagers: see list16
Bulk Api Vendors: see list44
Clinical Trials: see list40
Patent Applications: see list4,120
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:entacapone at DailyMed

Pharmacology for Ingredient: entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
ENTACAPONE
entacapone
TABLET;ORAL202394-001May 13, 2013DISCNNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ENTACAPONE
entacapone
TABLET;ORAL203437-001Jun 19, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Wockhardt Ltd
ENTACAPONE
entacapone
TABLET;ORAL078941-001Aug 16, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
ENTACAPONE
entacapone
TABLET;ORAL090690-001Jul 16, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999ABRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: entacapone

Country Document Number Estimated Expiration
Turkey200100752► Subscribe
Eurasian Patent Organization003282► Subscribe
Yugoslavia19301► Subscribe
Norway20011278► Subscribe
Georgia, Republic ofP20033062► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
AstraZeneca
Julphar
McKinsey
Citi
Express Scripts
Moodys
Medtronic
Fuji
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot